(RS)-warfarin
group of stereoisomers
Ratings
0
Nobody has rated this yet. Be the first!
A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome
Managing patients who are receiving warfarin or a direct oral anticoagulant and need an elective surgery or procedure
Warfarin versus aspirin in patients with reduced cardiac ejection fraction (WARCEF): rationale, objectives, and design
Is rivaroxaban noninferior to standard warfarin therapy in preventing recurrent PE and DVT?
Impact of genotype-guided dosing on anticoagulation visits for adults starting warfarin: a randomized controlled trial.
Impact of direct-acting oral anticoagulants and warfarin on postendoscopic GI bleeding and thromboembolic events in patients undergoing elective endoscopy
Genetic testing before anticoagulation? A systematic review of pharmacogenetic dosing of warfarin
The Influence of Patient Adherence on Anticoagulation Control With Warfarin
Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups